BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 34577878)

  • 1. Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.
    Del Toro-Pagán NM; Matos A; Thacker D; Turgeon J; Amin NS; Michaud V
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics and Drug-Induced Phenoconversion Informed Medication Safety Review in the Management of Pain Control and Quality of Life: A Case Report.
    Muhn S; Amin NS; Bardolia C; Del Toro-Pagán N; Pizzolato K; Thacker D; Turgeon J; Tomaino C; Michaud V
    J Pers Med; 2022 Jun; 12(6):. PubMed ID: 35743759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist assessment of drug-gene interactions and drug-induced phenoconversion in major depressive disorder: a case report.
    Del Toro-Pagán NM; Matos A; Bardolia C; Michaud V; Turgeon J; Amin NS
    BMC Psychiatry; 2022 Jan; 22(1):46. PubMed ID: 35057765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacist Consult Reports to Support Pharmacogenomics Report Interpretation.
    Bright D; Saadeh C; DeVuyst-Miller S; Sohn M; Choker A; Langerveld A
    Pharmgenomics Pers Med; 2020; 13():719-724. PubMed ID: 33328756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case Report: Performing a Medication Safety Review Assisted by Pharmacogenomics to Explain a Prescribing Cascade Resulting in a Patient Fall.
    Russell J; Arwood MJ; Toro-Pagán NMD; Amin NS; Cambridge MD; Turgeon J; Michaud V
    Medicina (Kaunas); 2023 Jan; 59(1):. PubMed ID: 36676742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenetic Testing in a 70-Year-Old Woman with Polypharmacy and Multiple Comorbidities: A Case Report.
    Jessop JP; Russell J; DeJesus A; Bardolia C; Hanna A; Turgeon J; Michaud V; Amin NS
    Am J Case Rep; 2023 Feb; 24():e938850. PubMed ID: 36804920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Pharmacogenomics on Pediatric Psychotropic Medication Prescribing in an Ambulatory Care Setting.
    Tonti E; Lee YM; Gruenke N; Ferren J; Stutzman DL
    J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):52-60. PubMed ID: 38377527
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health Setting.
    Mostafa S; Polasek TM; Sheffield LJ; Huppert D; Kirkpatrick CMJ
    Front Psychiatry; 2021; 12():724170. PubMed ID: 34489765
    [No Abstract]   [Full Text] [Related]  

  • 10. CYP2D6 pharmacogenetics and phenoconversion in personalized medicine.
    Nahid NA; Johnson JA
    Expert Opin Drug Metab Toxicol; 2022 Nov; 18(11):769-785. PubMed ID: 36597259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study.
    Scherf-Clavel M; Frantz A; Eckert A; Weber H; Unterecker S; Deckert J; Reif A; Hahn M
    Int J Clin Pharm; 2023 Oct; 45(5):1107-1117. PubMed ID: 37166747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomics in psychiatry - the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosing.
    Mostafa S; Polasek TM; Bousman CA; Müeller DJ; Sheffield LJ; Rembach J; Kirkpatrick CM
    Pharmacogenomics; 2022 Oct; 23(15):857-867. PubMed ID: 36169629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of targeted vs. expanded pharmacogenomic testing: What are we missing?
    Chambal M; Forsthoffer C; Egnaczyk A; Seitz M; Grande K; Ashcraft K; Wick JA; Blaxall BC
    J Am Pharm Assoc (2003); 2023; 63(3):939-945. PubMed ID: 37024375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics and phenoconversion: the influence on side effects experienced by psychiatric patients.
    den Uil MG; Hut HW; Wagelaar KR; Abdullah-Koolmees H; Cahn W; Wilting I; Deneer VHM
    Front Genet; 2023; 14():1249164. PubMed ID: 37693320
    [No Abstract]   [Full Text] [Related]  

  • 15. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
    Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
    Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications for pharmacogenomics in pharmacy practice: A scoping review.
    Hayashi M; Hamdy DA; Mahmoud SH
    Res Social Adm Pharm; 2022 Jul; 18(7):3094-3118. PubMed ID: 34474980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of a Standardized Medication Therapy Management Plus Approach within Primary Care.
    Schwartz EJ; Turgeon J; Patel J; Patel P; Shah H; Issa AM; Knowlton OV; Knowlton CH; Bain KT
    J Am Board Fam Med; 2017; 30(6):701-714. PubMed ID: 29180545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
    Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
    J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Pain Management in a CYP2D6 Poor Metabolizer: A Case Report for Oxycodone.
    Pednekar D; Russell J; Bardolia C; Thacker D; Amin NS
    Sr Care Pharm; 2024 Apr; 39(4):137-142. PubMed ID: 38528335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the clinical utility of pharmacogenetic guidance in a comprehensive medication management service.
    Rodríguez-Escudero I; Cedeño JA; Rodríguez-Nazario I; Reynaldo-Fernández G; Rodríguez-Vera L; Morales N; Jiménez-Vélez B; Ruaño G; Duconge J
    J Am Coll Clin Pharm; 2020 Sep; 3(6):1028-1037. PubMed ID: 32964197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.